-
Document de presse | 2023.10.25
The SARS-CoV-2 virus can migrate within neurons and infect the brain
The emergence of different variants of SARS-CoV-2 has produced a wide range of clinical profiles and symptoms in patients. For the first time, researchers at the Institut Pasteur and Université Paris Cité have demonstrated, in an animal model, a characteristic common to several SARS-CoV-2 variants: the ability to infect the central nervous system. The study confirms that SARS-CoV-2 is capable of...
-
News | 2023.11.02
The 40-year fight against HIV: we speak to Pauline Londeix, former Vice-President of Act Up-Paris and co-founder of OTMeds
In 1983 the AIDS virus, HIV, was isolated by virologists at the Institut Pasteur. There was no treatment at the time, and individuals infected with HIV generally died from this new disease. But in 1996, highly-active antiretroviral therapy (HAART) was introduced in the Global North, before becoming available in the Global South from 2001 onwards. Pauline Londeix, former Vice-President of Act Up-...
-
News | 2023.11.09
The 40-year fight against HIV: we speak to Florence Thune, Executive Director of Sidaction
In 1983 the AIDS virus, HIV, was isolated by virologists at the Institut Pasteur. At the time, there were widespread misconceptions of the virus and the way it was transmitted, and people living with HIV were the target of considerable discrimination. Today, huge strides have been made in science and knowledge. But as Florence Thune, Executive Director of French HIV/AIDS charity Sidaction reminds...
-
News | 2023.11.23
The 40-year fight against HIV: we speak to Marc Dixneuf, CEO of AIDES
In 1983 the AIDS virus, HIV, was isolated by virologists at the Institut Pasteur. Forty years later, HIV-positive patients can live with the virus if they are diagnosed in time and receive the right treatment. Treatments are constantly being improved – great strides are being made as a result of close cooperation between patients, caregivers and scientists. They are the bedrock of the 40-year...
-
News | 2023.11.16
The 40-year fight against HIV: we speak to Jennifer Pasquier, Scientific Director at Sidaction
In 1983, the AIDS virus, HIV, was isolated by virologists at the Institut Pasteur. This new virus, which was completely unknown at the time, was a source of fear and rejection for infected people. And while there have been advances in scientific knowledge over the decades – for example, we now know that if a virus cannot be detected in the blood, it cannot be transmitted –, there are still many...
-
Fiche maladie | 2023.11.06
Crimean-Congo hemorrhagic fever
Crimean-Congo hemorrhagic fever (CCHF) is a disease caused by a virus of the same name. In most cases, the infection is mild, but it can be severe or even fatal. The main route of transmission of the virus to humans is bites from ticks of the genus Hyalomma.
-
Document de presse | 2023.11.06
The CNES, the Institut Pasteur and SupBiotech are ready to send the “Cerebral Ageing” experiment to the International Space Station
Scheduled for early November, the Cerebral Ageing experiment will depart for the International Space Station (ISS) from Cape Canaveral, Florida, inside a Dragon spacecraft atop a Falcon 9 launcher. The experiment aims firstly to create the conditions for studying complex human cellular structures in vitro over long periods in space. It subsequently seeks to analyse the effects of long-term space...
-
Document de presse | 2023.11.15
The Institut Pasteur announces the launch of the Pasteur Foundation – UK
London, November 15, 2023 - The Institut Pasteur announces the launch of the Pasteur Foundation – UK, a private non-profit foundation aiming to raise awareness and funds for scientific cooperations between the Institut Pasteur in Paris and scientific institutions in the UK.Pandemics, antimicrobial resistance, neurodegenerative diseases and autism are among the many public health challenges the...
-
News | 2023.11.14
Discovery of peritumoral stromal cells that regulate antitumor immunity
A team from the Institut Pasteur has discovered a new population of cells that develops around a tumor mass. This discovery opens up a new avenue of treatment for solid tumors. This offers hope for improving the treatment of cancers for which immunotherapies are often ineffective, such as pancreatic, breast and prostate cancer.
-
Document de presse | 2023.10.19
Genes fuelling antibiotic resistance in Yemen cholera outbreak uncovered
An international collaborative research effort involving scientists from the Wellcome Sanger Institute, the University of Toronto, the Institut Pasteur and Sana'a University has revealed the source of antibiotic resistance that emerged in bacteria driving the cholera outbreak that is currently affecting Yemen. The results of their research, published on September 28, 2023 in the journal Nature...
